|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Bispebjerg Hospital |
| Information provided by: | Bispebjerg Hospital |
| ClinicalTrials.gov Identifier: | NCT00483145 |
Purpose
To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.
| Condition | Intervention |
|
Acne Vulgaris and Rosacea |
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate) |
| MedlinePlus related topics: | Acne Rosacea |
| Study Type: | Interventional |
| Study Design: | Randomized, Single Blind, Active Control, Single Group Assignment |
| Official Title: | Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea |
| Study Start Date: | November 2006 |
| Study Completion Date: | November 2007 |
| Arms | Assigned Interventions |
|
1: Active Comparator
Long-pulsed dye laser (Candela)
|
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser |
|
2: Active Comparator
Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
|
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate) |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Responsible Party: | Bispebjerg Hospital ( Merete Hædersdal ) |
| Study ID Numbers: | KF-01-328309 |
| First Received: | June 4, 2007 |
| Last Updated: | June 2, 2008 |
| ClinicalTrials.gov Identifier: | NCT00483145 |
| Health Authority: | Denmark: The Ministry of the Interior and Health |
|
|
|